ATC
ZBH icon

Advantage Trust Company’s Zimmer Biomet ZBH Stock Holding History

Advantage Trust Company’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-500
Closed -$45.6K – 209
2025
Q2 		$45.6K Hold
500
– – 0.02% 129
2025
Q1 		$56.6K Hold
500
– – 0.03% 90
2024
Q4 		$52.8K Buy
+500
New +$53.6K 0.03% 100

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Advantage Trust Company's ZBH Position: Q3 2025 in Review

Advantage Trust Company sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 500 shares — an estimated $45.6K sold.

Advantage Trust Company first reported a position in ZBH in Q4 2024 and held it in 3 quarters. The position peaked at $56.6K in Q1 2025. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

  • Advantage Trust Company reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
  • Advantage Trust Company sold 500 Zimmer Biomet shares in Q3 2025, an estimated $45.6K.
  • Advantage Trust Company first reported a position in Zimmer Biomet in Q4 2024 and held it in 3 quarters.
  • Advantage Trust Company's Zimmer Biomet position peaked at $56.6K in Q1 2025.
  • 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Advantage Trust Company's 13F filing for Q3 2025, filed 3 Nov 2025.